Companion Animal Vaccines Market Reaches $7.41 Billion In 2026: Forecast And Growth Opportunities
Featuring market attractiveness scoring, total addressable market sizing, company benchmarking matrices, interactive Excel dashboards, deeper supply chain intelligence, emerging startup tracking, and granular product-level insights, The Business Research Company’s 2026 market reports are built to deliver research that is both more actionable and more strategically valuable.
Companion Animal Vaccines Market Expansion Outlook: What Revenue Opportunities Are Ahead?
The companion animal vaccines market has experienced rapid expansion in recent years. It will grow from $4. 55 billion in 2025 to $5. 01 billion in 2026 at a compound annual growth rate (CAGR) of 10. 0%. This historical increase can be attributed to the rising occurrence of infectious diseases in companion animals, an increase in pet ownership worldwide, the expansion of veterinary clinic networks, heightened awareness of preventive pet healthcare, and the introduction of core vaccination programs for pets.
The companion animal vaccines market is anticipated to experience substantial growth in the coming years, with its size projected to reach $7.41 billion by 2030, demonstrating a compound annual growth rate (CAGR) of 10.3%. This expansion during the forecast period is attributed to factors such as an increasing demand for personalized pet healthcare solutions, a rise in pet insurance coverage stimulating vaccination uptake, growing investment in advanced recombinant and mRNA vaccine platforms, the expansion of veterinary infrastructure in emerging markets, and an escalating focus on zoonotic disease prevention and global health security. Major trends expected in this period include heightened pet humanization leading to increased vaccination compliance and preventive healthcare adoption, a rising awareness of zoonotic disease transmission promoting routine immunization in companion animals, the broadening of veterinary healthcare infrastructure and clinic networks enhancing vaccine accessibility, greater use of combination and multivalent vaccines to reduce multiple injections and improve compliance, and the strengthening of regulatory mandates and pet travel requirements enforcing vaccination standards.
Get A Free Sample Report With In-Depth Market Insights:
Companion Animal Vaccines Market Opportunity Drivers: What’s Unlocking New Revenue Potential?
Elevated expenditures on pet healthcare are projected to boost the expansion of the companion animal vaccines market in the future. This spending encompasses the overall financial investment made by pet owners in veterinary services, preventative measures, pharmaceutical products, and other health-related items for their pets. The surge in pet healthcare spending, driven by the increasing trend of pet humanization where pets are regarded as family members, is fueling market growth by fostering greater investment in both preventive and routine veterinary care, such as vaccinations, crucial for ensuring the long-term health of animals. This escalating expenditure on pet healthcare directly stimulates the demand for companion animal vaccines, as pet owners increasingly opt for prophylactic measures to shield their animals from contagious and fatal illnesses. For example, data from March 2024 by the American Pet Products Association (APPA), a US-based pet industry trade group, indicated that sales of veterinary care and products in the United States grew from $35.9 billion in 2022 to $38.3 billion in 2023, marking an increase of $2.4 billion. Consequently, the growing spending on pet healthcare is a key factor propelling the expansion of the companion animal vaccines market.
Companion Animal Vaccines Market Segment Landscape: Which Areas Lead Development?
The companion animal vaccines market covered in this report is segmented –
1) By Product: Inactivated, Live Attenuated, Other Products
2) By Animal Type: Feline, Canine, Avian, Other Animal Types
3) By Route Of Administration: Oral, Parenteral, Other Routes Of Administration
4) By Material Type: Killed Or Inactivated Vaccines, Modified-Live Vaccines (MLV), Recombinant Vaccines, Subunit And mRNA-Based Vaccines
5) By Distribution Channel: Veterinary Hospitals, Veterinary Clinics, Pharmacies And Drug Stores, Other Distribution Channels
Subsegments:
1) By Inactivated: Killed Viral Vaccine, Killed Bacterial Vaccine, Toxoid Vaccine, Subunit Vaccine
2) By Live Attenuated: Modified Live Viral Vaccine, Modified Live Bacterial Vaccine, Chimeric Vaccine, Attenuated Parasite Vaccine
3) By Other Products: Combination Vaccine, Adjuvanted Vaccine, Autogenous Vaccine, Novel Platform Vaccine
Companion Animal Vaccines Market Innovation Trends Shaping Future Development
Leading companies in the companion animal vaccines market are concentrating on developing novel products, including injectable recombinant vaccines, to improve immunization effectiveness and enhance flexibility in administration. An injectable recombinant vaccine represents a biologically engineered immunization utilizing recombinant antigens to provoke a specific immune response in animals. For example, in November 2025, Zoetis Services LLC, a US-based animal health company, introduced Vanguard Recombishield. This is a non-adjuvanted, recombinant injectable vaccine that incorporates the pertactin protein, facilitating more accurate immune system targeting and lessening adverse reactions during application. It also provides a more comfortable and adaptable vaccination strategy, fostering better compliance and efficient prevention of respiratory infections in dogs.
Companion Animal Vaccines Market Leading Companies And Competitive Benchmarking
Major companies operating in the companion animal vaccines market are Boehringer Ingelheim International GmbH, Zoetis Inc., Ceva Santé Animale S. A., Virbac S. A., Phibro Animal Health Corporation, Neogen Corporation, Vetoquinol S. A., Norbrook Laboratories Limited, HIPRA S. A., Indian Immunologicals Limited, Vaxxinova International B. V., Bimeda Animal Health Limited, Laboratorios Calier S. A., Hester Biosciences Limited, ChoongAng Vaccine Laboratories Co. Ltd., Elanco Animal Health Incorporated, Bioveta a. s., CZ Veterinaria S. A., Intervet Inc. (Merck Animal Health), Brilliant Bio Pharma Private Limited, Durvet Inc., Kyoritsu Seiyaku Corporation
View The Full Companion Animal Vaccines Market Report:
Companion Animal Vaccines Market Largest Region By Revenue And Market Share
North America was the largest region in the companion animal vaccines market in 2025. Asia-Pacific is expected to be the fastest-growing region in the forecast period. The regions covered in the companion animal vaccines market report are Asia-Pacific, South East Asia, Western Europe, Eastern Europe, North America, South America, Middle East and Africa.
Reach Out To Our Team:
The Business Research Company: https://www.thebusinessresearchcompany.com/
Americas: +1 310-496-7795
Asia: +44 7882 955267 & +91 8897263534
Europe: +44 7882 955267
Email us at: marketing@tbrc.info
Follow us on:
LinkedIn: https://in.linkedin.com/company/the-business-research-company
YouTube: https://www.youtube.com/channel/UC24_fI0rV8cR5DxlCpgmyFQ
Global Market Model: https://www.thebusinessresearchcompany.com/global-market-model
